No increase of serum autoantibodies during therapy with recombinant human interferon-β1a in relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

No increase of serum autoantibodies during therapy with recombinant human interferon-β1a in relapsing-remitting multiple sclerosis

Published:2009-01-29 Issue:6 Volume:96 Page:372-374
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Colosimo Carlo,Pozzilli Carlo,Frontoni Marco,Farina Deborah,Koudriavtseva Tatiana,Gasperini Claudio,Salvetti Marco,Valesini Guido

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1997.tb00300.x/fullpdf

Reference13 articles.

1. Interferon beta-lb in the treatment of multiple sclerosis: final outcome of the randomized controlled trial;The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group;Neurology,1995

2. Intramuscular interferon Beta-la for disease progression in relapsing multiple sclerosis;Jacobs;Ann Neurol,1996

3. Exacerbations of symptoms of autoimmune disease in patients receiving alpha-interferon therapy;Conlon;Cancer,1990

4. Interferons and multiple sclerosis;ARNASON;Clin Neuropharmacol,1994

5. Antinuclear antibodies in multiple sclerosis;Dore-Duffy;Arch Neurol,1982

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon beta;Meyler's Side Effects of Drugs;2016

2. Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis;Neuroscience Letters;2015-10

3. Hughes syndrome and Multiple sclerosis;Lupus;2014-10-17

4. High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes;Neurological Sciences;2014-05-22

5. Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study;Multiple Sclerosis Journal;2014-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3